New Edge Advisors, LLC Novartis Ag Transaction History

New Edge Advisors, LLC

  • $15 Billion
  • Q3 2024

A detailed history of New Edge Advisors, LLC transactions in Novartis Ag stock. As of the latest transaction made, New Edge Advisors, LLC holds 85,386 shares of NVS stock, worth $8.4 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
85,386
Previous 105,157 18.8%
Holding current value
$8.4 Million
Previous $11.2 Million 12.27%
% of portfolio
0.07%
Previous 0.08%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$106.13 - $120.89 $2.1 Million - $2.39 Million
-19,771 Reduced 18.8%
85,386 $9.82 Million
Q2 2024

Aug 15, 2024
SELL
$92.57 - $107.37 $26.3 Million - $30.6 Million
-284,568 Reduced 73.02%
105,157 $11.2 Million
Q1 2024

May 14, 2024
SELL
$95.27 - $108.47 $165,102 - $187,978
-1,733 Reduced 0.44%
389,725 $37.7 Million
Q4 2023

Feb 13, 2024
BUY
$92.27 - $101.54 $1.76 Million - $1.93 Million
19,029 Added 5.11%
391,458 $39.5 Million
Q3 2023

Nov 14, 2023
BUY
$94.73 - $105.13 $824,908 - $915,472
8,708 Added 2.39%
372,429 $37.9 Million
Q2 2023

Aug 14, 2023
SELL
$92.52 - $104.91 $409,586 - $464,436
-4,427 Reduced 1.2%
363,721 $36.7 Million
Q1 2023

May 12, 2023
BUY
$80.03 - $92.81 $26.4 Million - $30.6 Million
330,084 Added 867.18%
368,148 $33.9 Million
Q4 2022

Feb 14, 2023
SELL
$75.55 - $92.52 $78,798 - $96,498
-1,043 Reduced 2.67%
38,064 $3.45 Million
Q3 2022

Nov 14, 2022
SELL
$74.61 - $87.26 $64,761 - $75,741
-868 Reduced 2.17%
39,107 $2.97 Million
Q2 2022

Aug 09, 2022
BUY
$80.52 - $93.75 $136,400 - $158,812
1,694 Added 4.43%
39,975 $3.38 Million
Q1 2022

May 13, 2022
BUY
$80.11 - $90.62 $76,344 - $86,360
953 Added 2.55%
38,281 $3.36 Million
Q4 2021

Feb 17, 2022
BUY
$79.7 - $88.13 $1.18 Million - $1.3 Million
14,749 Added 65.32%
37,328 $3.27 Million
Q3 2021

Oct 29, 2021
SELL
$81.78 - $95.14 $52,829 - $61,460
-646 Reduced 2.78%
22,579 $1.85 Million
Q2 2021

Jul 22, 2021
SELL
$85.24 - $94.15 $42,449 - $46,886
-498 Reduced 2.1%
23,225 $2.12 Million
Q1 2021

Apr 26, 2021
SELL
$83.5 - $98.47 $210,253 - $247,947
-2,518 Reduced 9.6%
23,723 $2.03 Million
Q4 2020

Jan 27, 2021
SELL
$78.07 - $94.43 $1.53 Million - $1.85 Million
-19,596 Reduced 42.75%
26,241 $2.48 Million
Q3 2020

Nov 03, 2020
SELL
$82.14 - $91.0 $14.9 Million - $16.5 Million
-181,633 Reduced 79.85%
45,837 $3.99 Million
Q2 2020

Jul 29, 2020
BUY
$80.93 - $91.1 $2.68 Million - $3.02 Million
33,141 Added 17.05%
227,470 $19.9 Million
Q1 2020

May 04, 2020
BUY
$70.67 - $99.01 $1.29 Million - $1.81 Million
18,255 Added 10.37%
194,329 $16 Million
Q4 2019

Jan 31, 2020
BUY
$84.35 - $95.37 $1.51 Million - $1.7 Million
17,856 Added 11.29%
176,074 $16.7 Million
Q3 2019

Nov 06, 2019
BUY
$85.54 - $94.26 $12.6 Million - $13.9 Million
147,189 Added 1334.56%
158,218 $13.7 Million
Q2 2019

Aug 05, 2019
BUY
$75.4 - $92.8 $71,479 - $87,974
948 Added 9.4%
11,029 $1.01 Million
Q1 2019

May 14, 2019
SELL
$75.32 - $86.15 $5.71 Million - $6.53 Million
-75,766 Reduced 88.26%
10,081 $969,000
Q1 2019

May 09, 2019
BUY
$75.32 - $86.15 $5.78 Million - $6.61 Million
76,705 Added 839.04%
85,847 $855,000
Q4 2018

Jan 29, 2019
SELL
$73.66 - $82.02 $34,472 - $38,385
-468 Reduced 4.87%
9,142 $784,000
Q3 2018

Oct 29, 2018
BUY
$66.94 - $77.43 $8,434 - $9,756
126 Added 1.33%
9,610 $828,000
Q2 2018

Jul 19, 2018
SELL
$64.91 - $73.36 $197,910 - $223,674
-3,049 Reduced 24.33%
9,484 $709,000
Q1 2018

May 11, 2018
BUY
$70.39 - $84.15 $71,305 - $85,243
1,013 Added 8.79%
12,533 $997,000
Q4 2017

Feb 08, 2018
SELL
$72.33 - $77.64 $34,139 - $36,646
-472 Reduced 3.94%
11,520 $993,000
Q3 2017

Nov 13, 2017
SELL
$74.14 - $77.27 $45,596 - $47,521
-615 Reduced 4.88%
11,992 $1.03 Million
Q2 2017

Aug 16, 2017
BUY
N/A
12,607
12,607 $0

Others Institutions Holding NVS

# of Institutions
1,437
Shares Held
131M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track New Edge Advisors, LLC Portfolio

Follow New Edge Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email